Fractured Neck of FemurNCT02163343
Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur
An observational study of Fractured Neck of Femur, run by Royal Berkshire NHS Foundation Trust at 1 site in United Kingdom.
Trial summary
Elevated serum metal ions are well recognized in metal-on-metal articulations in total hip replacements. The objective of the study is to see if the Cathcart / Corail device implanted during a hemiarthroplasty (replacement of one half of the hip joint) results in elevated serum metal ion levels (cobalt \& chromium)… Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Fractured Neck of Femur
- How many people
- 56 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- Jun 2014to Dec 2019
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: 100 patients receiving a Cathcart Hemiarthroplasty for intracapsular fractured neck of femur at the Royal Berkshire Hospital
Who may be able to join
- All patients who received a Cathcart Hemiarthroplasty and are able to attend for blood testing and complete a questionnaire (Oxford Hip Score).
Who cannot join
- Those patients too frail or who now live too far away to attend for blood testing.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
Royal Berkshire NHS Foundation Trust
Reading, Berkshire, RG15AN
About this study
Elevated serum metal ions are well recognized in metal-on-metal articulations in total hip replacements. The objective of the study is to see if the Cathcart / Corail device implanted during a hemiarthroplasty (replacement of one half of the hip joint) results in elevated serum metal ion levels (cobalt \& chromium) and to see if there is an association between size of Cathcart head used and metal ion levels.
Read the detailed description
Hip hemiarthroplasty is a very common operation. The investigator's organisation (RBH) performs approximately 140 Cathcart Hemiarthroplasty procedures each year and over 500 Cathcart/Corail have been implanted since their introduction to the department in March 2010. The clinical outcome is good with a low mortality rate at both 30 days and one year. The implant is well established in the department and there has been a reduction in the need for revision procedures compared with the previously used cemented Exeter Trauma Stem (ETS).
Elevated serum metal ion levels (cobalt and chromium) are well recognised in metal-on-metal (MoM) articulations in total hip arthroplasty. The Medicines and Healthcare Products Regulatory Agency have issued guidelines on follow up of all patients who underwent either MoM total hip replacement or resurfacing. All patients must undergo serum metal ion levels testing with recommended upper limits of 119 nmol/L for cobalt and 134.5 nmol/L for Chromium. Above those levels further surveillance or revision is required. It is not known whether the large diameter Cathcart head on the Corail stem also results in elevated serum metal ion levels (above the MHRA guidelines). Research published in 2012 has demonstrated that there is excessive wear and corrosion between the trunnion and taper of the ASR XL head, which is similar in design to the Cathcart head, utilising a taper insert within the head. Concern has therefore been raised that there may be excessive wear, and increased serum metal ion levels, in patients who have undergone Cathcart hemiarthroplasty.
The investigators propose to measure serum cobalt and chromium metal ions (normal levels are under 30nmol/l) in participants who have received a Cathcart Hemiarthroplasty greater than one year ago and ask each participant to complete the twelve question Oxford hip score .This is to identify whether the levels are elevated and whether clinical scores are able to detect those patients who may have a problem related to increased metal ion levels, and to obtain a normal distribution. It is known that metal ion levels are elevated at one year and the increase can be maintained for several years subsequently following metal-on-metal total hip replacements.
From a statistical perspective, this is a pragmatic study to see if there is an association between Cathcart Hemiarthroplasty and raised serum metal ion levels.
The procedure will involve writing to the patient to invite them to enter the study. If they are interested (through return of the reply slip or telephone call from the patient to the orthopaedic office) an appointment at the hospital will be arranged. Non return of the reply slip or no telephone contact from the patient will be regarded as the patient not wishing to take part. In clinic they will be assessed and further clarity given or any questions answered before informed consent is sought. Once consent has been obtained, the patient will complete the Oxford Hip Score questionnaire and a blood test for metal ion levels will be taken.
In year 2, a letter will be sent to General Practitioner (GP) requesting whether they would be able to perform a blood test for the study. At this time the patient's status would also be established. If the GP is willing to do the blood test a reminder letter will be sent to the patient inviting them to go to the GP or hospital for the second blood test. If the GP is unable to do the blood test, the letter to the patient will only give the option of going to the hospital for the blood test.
As the investigators have a large cohort of patients it may also be possible to identify an association between head diameter, clinical outcome and the risk of having elevated metal ion levels. This is important as smaller resurfacing components (diameter less than 51 mm) are at increased risk of elevated metal ion levels and the majority of fractured neck of femur patients are female who often require small components.
- Primary outcome: Serum Cobalt and Chromium Levels at one and two years.
- Secondary outcomes: Whether there is an association between i) Oxford Hip Score at one year, and, ii) head diameter and metal ion levels.
- Conditions
- Fractured Neck of Femur
- Keywords
- Serum metal ion levels, Cathcart/Corail hemiarthroplasty, Hip replacement
- Medical subject headings
- Femoral Neck Fractures
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| No treatment | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in serum metal ion level (Chromium and Cobalt) at year 2
Measured: One and two years post surgery
Secondary outcomes (1)
The association between Oxford Hip Score, head diameter and metal ion levels.
Whether there is an association between i) Oxford Hip Score at one year, and, ii) head diameter and metal ion levels and year one and year two.
Measured: up to two years post surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Jun 2014 (estimated)
- Study startJun 2014
- Primary completionApr 2018
- Study completionDec 2019 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Fractured Neck of FemurStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Retrospective
- Enrolment
- 56 participants (actual)
Sponsor and investigators
- Lead sponsor
- Royal Berkshire NHS Foundation Trust
- Sponsor type
- Other government
- Collaborators
- DePuy International
- Responsible party
- Sponsor
- Investigators
- Antonio Andrade, FRCS MSc, Principal investigator, Royal Berkshire NHS Foundation Trust
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02163343
- Sponsor's protocol ID
- 14/WS/0060
- Status last verified
- Oct 2019
- First submitted
- 6 Jun 2014
- Last updated
- 31 Oct 2019
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 31 Oct 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Serum Metal Ion Levels in Patients Who Underwent Cathcart/Corail Hemiarthroplasty for Fractured Neck of Femur
- ClinicalTrials.gov ID
- NCT02163343
- Acronym / sponsor ID
- 14/WS/0060
- Conditions
- Fractured Neck of Femur
- Keywords
- Serum metal ion levels, Cathcart/Corail hemiarthroplasty, Hip replacement
- Study type
- Observational
- Recruitment status
- Suspended
- Enrolment
- 56 participants (actual)
- Lead sponsor
- Royal Berkshire NHS Foundation TrustOther government
- Collaborators
- DePuy International
- Study start
- Jun 2014 (actual)
- Primary completion
- Apr 2018 (actual)
- Study completion
- Dec 2019 (estimated)
- First posted
- 13 Jun 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Elevated serum metal ions are well recognized in metal-on-metal articulations in total hip replacements. The objective of the study is to see if the Cathcart / Corail device implanted during a hemiarthroplasty (replacement of one half of the hip joint) results in elevated serum metal ion levels (cobalt \& chromium) and to see if there is an association between size of Cathcart head used and metal ion levels.
Detailed description
Hip hemiarthroplasty is a very common operation. The investigator's organisation (RBH) performs approximately 140 Cathcart Hemiarthroplasty procedures each year and over 500 Cathcart/Corail have been implanted since their introduction to the department in March 2010. The clinical outcome is good with a low mortality rate at both 30 days and one year. The implant is well established in the department and there has been a reduction in the need for revision procedures compared with the previously used cemented Exeter Trauma Stem (ETS).
Elevated serum metal ion levels (cobalt and chromium) are well recognised in metal-on-metal (MoM) articulations in total hip arthroplasty. The Medicines and Healthcare Products Regulatory Agency have issued guidelines on follow up of all patients who underwent either MoM total hip replacement or resurfacing. All patients must undergo serum metal ion levels testing with recommended upper limits of 119 nmol/L for cobalt and 134.5 nmol/L for Chromium. Above those levels further surveillance or revision is required. It is not known whether the large diameter Cathcart head on the Corail stem also results in elevated serum metal ion levels (above the MHRA guidelines). Research published in 2012 has demonstrated that there is excessive wear and corrosion between the trunnion and taper of the ASR XL head, which is similar in design to the Cathcart head, utilising a taper insert within the head. Concern has therefore been raised that there may be excessive wear, and increased serum metal ion levels, in patients who have undergone Cathcart hemiarthroplasty.
The investigators propose to measure serum cobalt and chromium metal ions (normal levels are under 30nmol/l) in participants who have received a Cathcart Hemiarthroplasty greater than one year ago and ask each participant to complete the twelve question Oxford hip score .This is to identify whether the levels are elevated and whether clinical scores are able to detect those patients who may have a problem related to increased metal ion levels, and to obtain a normal distribution. It is known that metal ion levels are elevated at one year and the increase can be maintained for several years subsequently following metal-on-metal total hip replacements.
From a statistical perspective, this is a pragmatic study to see if there is an association between Cathcart Hemiarthroplasty and raised serum metal ion levels.
The procedure will involve writing to the patient to invite them to enter the study. If they are interested (through return of the reply slip or telephone call from the patient to the orthopaedic office) an appointment at the hospital will be arranged. Non return of the reply slip or no telephone contact from the patient will be regarded as the patient not wishing to take part. In clinic they will be assessed and further clarity given or any questions answered before informed consent is sought. Once consent has been obtained, the patient will complete the Oxford Hip Score questionnaire and a blood test for metal ion levels will be taken.
In year 2, a letter will be sent to General Practitioner (GP) requesting whether they would be able to perform a blood test for the study. At this time the patient's status would also be established. If the GP is willing to do the blood test a reminder letter will be sent to the patient inviting them to go to the GP or hospital for the second blood test. If the GP is unable to do the blood test, the letter to the patient will only give the option of going to the hospital for the blood test.
As the investigators have a large cohort of patients it may also be possible to identify an association between head diameter, clinical outcome and the risk of having elevated metal ion levels. This is important as smaller resurfacing components (diameter less than 51 mm) are at increased risk of elevated metal ion levels and the majority of fractured neck of femur patients are female who often require small components.
- Primary outcome: Serum Cobalt and Chromium Levels at one and two years.
- Secondary outcomes: Whether there is an association between i) Oxford Hip Score at one year, and, ii) head diameter and metal ion levels.
Study design
- Observational model
- Cohort
- Time perspective
- Retrospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| No treatment | – | – |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- 100 patients receiving a Cathcart Hemiarthroplasty for intracapsular fractured neck of femur at the Royal Berkshire Hospital
Key inclusion criteria (1 listed)
- All patients who received a Cathcart Hemiarthroplasty and are able to attend for blood testing and complete a questionnaire (Oxford Hip Score).
Key exclusion criteria (1 listed)
- Those patients too frail or who now live too far away to attend for blood testing.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Change in serum metal ion level (Chromium and Cobalt) at year 2
Time frame: One and two years post surgery
1 secondary outcome
The association between Oxford Hip Score, head diameter and metal ion levels.
Time frame: up to two years post surgery
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 31 Oct 2019.
Related trials for Fractured Neck of Femur
Not yet recruiting
Lumbar Erector Spinae Plane Block Versus PENG Block for Hip Fracture Surgery
Femur Neck Fracture, Hip Fractures
Active, not recruiting
Lumbar-Sacral Plexus Block vs Fascia Iliaca Block Plus Low-Dose Spinal Anesthesia for Femoral Neck Fracture Surgery
Femoral Neck Fractures, Nerve Block
Active, not recruitingPhase 2
BDSF Vs DHS With Anterotational Screw in Vertical FNF
Evaluation of BDSF in FNF
RecruitingObservational study
Z1 Hip System: Post-Market Clinical Follow Up Study
Hip Osteoarthritis, Acute Traumatic Fracture of the Femoral Head or Neck
Not yet recruiting
Trochanteric Bursa Repair and Lateral Hip Pain After Hemiarthroplasty for Femoral Neck Fracture
Femoral Neck Fracture
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Antonio Andrade, FRCS MSc principal investigator
Royal Berkshire NHS Foundation Trust
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Fractured Neck of Femur, run by Royal Berkshire NHS Foundation Trust at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: paused, as of the sponsor's last update on 31 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in serum metal ion level (Chromium and Cobalt) at year 2 (time frame: One and two years post surgery). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Oct 2019.